Lv712
5000 积分 2024-05-28 加入
Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL Amyloidosis
3天前
已完结
PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
1个月前
已完结
Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019–2024)
1个月前
已完结
Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to KIF18A Inhibition
3个月前
已完结
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
3个月前
已完结
Alpelisib-induced severe interstitial lung disease: case report
4个月前
已关闭
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
5个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
5个月前
已完结
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents
6个月前
已关闭
A patent review of BRD4 inhibitors (2013-2019)
6个月前
已完结
皖公网安备34019202002308
